Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
- Formed New AAV Manufacturing and Innovation Business with Oxford Biomedica to Leverage Homology’s Process Development and Manufacturing Capabilities - - Received $130 Million Non-Dilutive... | March 23, 2022
Source: marketscreener.com